Daily Piece: Incretin Based Drugs and Cancer of Bile Ducts

In the British Medical Journal (BMJ), an interesting population based cohort study found that use of incretin based drugs (dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists) might be associated with an increased risk of cholangiocarcinoma (cancer of bile ducts) in adults with type 2 diabetes. While this certainly does not prove cause and effect, it is certainly an interesting finding.  Please click below read more about this study and cholangiocarcinoma (cancer of bile duct).



Intrahepatic Cholangiocarcinoma
This image has an empty alt attribute; its file name is Twitter-Profile-Picture-01-300x300.jpg

Please share your thoughts and subscribe to receive my blogs.

#incretin #drugs #cancer

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.

Leave a Reply

Your email address will not be published. Required fields are marked *